NASDAQ:DYNT - Dynatronics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.99 -0.07 (-3.40 %) (As of 03/26/2019 07:56 AM ET)Previous Close$2.06Today's Range$1.96 - $2.0252-Week Range$1.88 - $3.60Volume4,914 shsAverage Volume9,368 shsMarket Capitalization$16.44 millionP/E Ratio-4.97Dividend YieldN/ABeta-0.12 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah. Receive DYNT News and Ratings via Email Sign-up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DYNT Previous Symbol CUSIPN/A CIK720875 Webwww.dynatronics.com Phone801-568-7000Debt Debt-to-Equity Ratio0.32 Current Ratio1.51 Quick Ratio0.66Price-To-Earnings Trailing P/E Ratio-4.97 Forward P/E Ratio-11.06 P/E GrowthN/A Sales & Book Value Annual Sales$64.42 million Price / Sales0.26 Cash Flow$0.0603 per share Price / Cash Flow33.00 Book Value$1.20 per share Price / Book1.66Profitability EPS (Most Recent Fiscal Year)($0.40) Net Income$-1,600,000.00 Net Margins-2.94% Return on Equity-10.67% Return on Assets-2.58%Miscellaneous Employees323 Outstanding Shares8,260,000Market Cap$16.44 million Next Earnings Date5/21/2019 (Estimated) OptionableNot Optionable Dynatronics (NASDAQ:DYNT) Frequently Asked Questions What is Dynatronics' stock symbol? Dynatronics trades on the NASDAQ under the ticker symbol "DYNT." How were Dynatronics' earnings last quarter? Dynatronics Co. (NASDAQ:DYNT) issued its earnings results on Wednesday, February, 13th. The medical equipment provider reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.04. The medical equipment provider had revenue of $15.44 million for the quarter, compared to the consensus estimate of $16.28 million. Dynatronics had a negative net margin of 2.94% and a negative return on equity of 10.67%. View Dynatronics' Earnings History. When is Dynatronics' next earnings date? Dynatronics is scheduled to release their next quarterly earnings announcement on Tuesday, May 21st 2019. View Earnings Estimates for Dynatronics. What price target have analysts set for DYNT? 1 analysts have issued 12 month price targets for Dynatronics' stock. Their predictions range from $4.00 to $4.00. On average, they anticipate Dynatronics' share price to reach $4.00 in the next year. This suggests a possible upside of 101.0% from the stock's current price. View Analyst Price Targets for Dynatronics. What is the consensus analysts' recommendation for Dynatronics? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dynatronics. Has Dynatronics been receiving favorable news coverage? Media headlines about DYNT stock have been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Dynatronics earned a news impact score of -1.4 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. Who are some of Dynatronics' key competitors? Some companies that are related to Dynatronics include Invo Bioscience (IVOB), Titan Medical (TMDI), Arch Therapeutics (ARTH), Spectral Medical (EDTXF), Motus GI (MOTS), Pro-Dex (PDEX), Repro-Med Systems (REPR), RA Medical Systems (RMED), AIT Therapeutics (AITB), Obalon Therapeutics (OBLN), Avinger (AVGR), Valeritas (VLRX), Hancock Jaffe Laboratories (HJLI), Nephros (NEPH) and SANUWAVE Health (SNWV). What other stocks do shareholders of Dynatronics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dynatronics investors own include Aptose Biosciences (APTO), Iovance Biotherapeutics (IOVA), Nymox Pharmaceutical (NYMX), Rigel Pharmaceuticals (RIGL), Aurora Cannabis (ACB), Arca Biopharma (ABIO), Allena Pharmaceuticals (ALNA), Athersys (ATHX), Biocept (BIOC) and Second Sight Medical Products (EYES). Who are Dynatronics' key executives? Dynatronics' management team includes the folowing people: Dr. Christopher Richard Von Jako, CEO & Director (Age 49)Mr. David A. Wirthlin, CFO & Sec. (Age 58)Mr. Terry M. Atkinson CPA, CGMA, Director of Accounting (Age 66)Mr. Daryl Connell, Chief Information Officer (Age 47)Mr. Skyler Black, Corp. Controller (Age 36) How do I buy shares of Dynatronics? Shares of DYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Dynatronics' stock price today? One share of DYNT stock can currently be purchased for approximately $1.9899. How big of a company is Dynatronics? Dynatronics has a market capitalization of $16.44 million and generates $64.42 million in revenue each year. The medical equipment provider earns $-1,600,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis. Dynatronics employs 323 workers across the globe. What is Dynatronics' official website? The official website for Dynatronics is http://www.dynatronics.com. How can I contact Dynatronics? Dynatronics' mailing address is 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT, 84121. The medical equipment provider can be reached via phone at 801-568-7000. MarketBeat Community Rating for Dynatronics (NASDAQ DYNT)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 178 (Vote Outperform)Underperform Votes: 194 (Vote Underperform)Total Votes: 372MarketBeat's community ratings are surveys of what our community members think about Dynatronics and other stocks. Vote "Outperform" if you believe DYNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DYNT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: Is a Roth IRA right for you?